Effects of Tribulus Terrestris in Women With Hypoactive Sexual Desire Disorder

Federal University of Minas Gerais

Status and phase

Completed

Phase 4

Conditions

Hypoactive Sexual Desire Disfunction

Treatments

Other: Placebo

Drug: tribulus terrestris

Study type

Interventional

Funder types

Other

Identifiers

NCT01971099

TTM1

Details and patient eligibility

About

Hypoactive Sexual Desire Disorder (HSDD) is the most prevalent female sexual dysfunction in society and is strongly linked to the quality of life of women. The androgen hormones decline over age in the premenopausal period, which occurs around 20 years. Tribulus terrestris is a plant native to India, recommended in the treatment of infertility, low libido and impotence. Its main active ingredient is the protodioscin, which has been attributed to an increase in testosterone levels and improved sexual function. The aim of this study is to evaluate the effects of Tribulus Terrestris in premenopausal women with HSDD.

Enrollment

44 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

regular menstrual cycle
with no use of hormonal contraception within the last 3 months
without any medication, drugs or alcohol.
Healthy patients without systemic or psychiatric disease

Exclusion criteria

Patients with amenorrhea and/or pregnant.
- Patients who underwent bilateral oophorectomy.
- Patient smoker (10 cigarettes per day).
- Patients with blood pressure > 160/90 mm Hg.
- Patient with breast or endometrial carcinoma.
- Patients with a history of myocardial infarction.
- Patient with Diabetes.
- Patient with vaginal bleeding from any source.
- Patients with hepatic injury.
- Patients with active thrombophlebitis or thromboembolic disorders recent
- Patients with interpersonal relationship problems with your relationship or partner
- Patients with sexual problems from your partner